SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
American Cannabis Company, Inc. (AMMJ) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 19/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — AMMJ
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.03
Book Value / Share$0.00
Revenue / Share$0.02
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$-0.11 |
$1.26M |
$-3.62M |
-287.5% |
| 2015 |
$-0.01 |
$2.8M |
$-516K |
-18.4% |
| 2016 |
$-0.01 |
$1.56M |
$-604K |
-38.7% |
| 2017 |
$-0.03 |
$2.44M |
$-1.49M |
-60.9% |
| 2018 |
$-0.02 |
$982.35K |
$-951K |
-96.8% |
| 2019 |
$-0.01 |
$2.13M |
$-302K |
-14.2% |
| 2020 |
$-0.01 |
$1.57M |
$-532K |
-33.9% |
| 2021 |
$-0.02 |
$2.43M |
$-1.44M |
-59.3% |
| 2022 |
$-0.01 |
$18.81M |
$-633K |
-3.4% |
| 2023 |
$-0.03 |
$2.48M |
$-3.66M |
-147.8% |
